Latest editorial in Liver International: RFA as an effective and safe treatment for iCCA, especially in cirrhosis. Cutoff: 2 cm results in⬇️recurrence and⬆️survival, aiding in early-stage definition.Alejandro Forner BCLC GROUP Ángeles García Criado onlinelibrary.wiley.com/doi/abs/10.111… onlinelibrary.wiley.com/doi/10.1111/li…

👏👏👏 gemma iserte 🙌🔝BCLC GROUP Hospital Clínic IDIBAPS @CIBERehd #LiverTwitter

🆕EASL #CPGs on the management of MASLD❗️ ✅Update on definitions, prevention, screening, diagnosis & treatment for #MASLD Full text👉bit.ly/3XeJnFc ✴️Joint publication with EASD & EASO❕ EASLnews EASL Education Aleksander Krag Debbie Shawcross

🚨 New Study Alert! 🚨 Our latest research in Journal of Hepatology highlights key findings on HCC recurrence post-resection. BCLC GROUP Hospital Clínic @CIBERehd IDIBAPS LiverUnit.Clinic.BCN #LiverCancer #LiverTwitter Carla Fuster Alba Díaz Alejandro Forner journal-of-hepatology.eu/article/S0168-…

This review underscores the relevance of the metabolic profile in patients with MASLD-associated hepatocellular carcinoma in risk stratification and therapeutic approaches Juan M Pericas Beatriz Mínguez Tacke Lab Sven Francque ow.ly/NjP650T5iwN

📖 Pseudoobstrucción intestinal crónica y cómo evitarla Carolina Malagelada y Luis G. Alcalá-González destacan los errores más comunes y ofrecen consejos prácticos para evitarlos. 🔗 ueg.eu/a/355 my_UEG Vall d'Hebron  #gastroenterologia #saludigestivo

📢 Paper recommendation Continuing medical education is a most! Congrats Luis Gerardo Alcala Gonzalez Vall d'Hebron 👏👏 🔗 ueg.eu/a/355

Hoy ha sido un gran día para mí. Gran día a nivel personal, profesional y académico. Agradezco a cada una de las personas que estuvieron apoyándome en el camino para conseguir este logro. Especialmente al BCLC GROUP y a Maria Reig que me apoyaron y orientaron en cada etapa.

🎗️On Liver Cancer Awareness Month, we unite with EASLnews, European Liver Patients' Association, ILCA, and #ILCM to share key messages on the situation of #LiverCancer in 🇪🇺. The📽️video below is the first one, with an inspiring message from Zorana Maravic, DiCE CEO, about how you can take

🆕REVIEW❕ Thyroid hormone receptor-β analogs for the treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH) #OpenAccess here👉journal-of-hepatology.eu/article/S0168-… #LiverTwitter

Very proud of leading this collaborative effort with my friend Ezequiel Mauro. It will surely not be our last collaboration. I would like to thank all authors for the outstanding work: you are all wonderful!

Please listen to our podcast on second-line treatment for advanced #HCC and when to switch Oncology Brothers Arndt Vogel Humanitas University Humanitas Milano

🆕EASL Clinical Practice Guidelines on the management of #hepatocellularcarcinoma❗️ ✅Updated advice for managing patients with #HCC & comprehensive review of pertinent data Full text👉bit.ly/3VKZmcy #CPGs #LiverTwitter EASLnews EASL Education Aleksander Krag

Resilience & patience pay off! Even after curing #HCV, the big challenge remains: #managing the residual risk of #HCC Promoting healthy #lifestylechanges & a multidisciplinary, nurse-led approach is key Read more: rdcu.be/d8v5l Barcelona Clinic Viral Hepatitis Group Hospital Clínic IDIBAPS

Example of the caveats of RFS as a major end-point in HCC clinical trials to file for drug approval. IMbrave050 negative for RFH. annalsofoncology.org/article/S0923-… (Neo)adyuvant systemic treatment is not recommended in pts treated w/ liver resection/local ablation.

Original Article Corticosteroids in severe alcohol-associated hepatitis? Not so fast: A systematic review of randomized controlled trials Shi, Pungwe et al. #LiverX tinyurl.com/mzzk8uar

🆕CPG in press❕ EASL Clinical Practice Guidelines on the management of extrahepatic cholangiocarcinoma Find it here👉bit.ly/4iTmgqI EASLnews EASL Education

🆕CPG in press❕ EASL Clinical Practice Guidelines on the management of hepatitis B virus infection Find it here👉bit.ly/4deZHf1 EASLnews EASL Education

🆕CPG in press❕ EASL Clinical Practice Guidelines on extrahepatic abdominal surgery in patients with cirrhosis and advanced chronic liver disease Find it here👉bit.ly/3GM9EEB EASLnews EASL Education

Three in five liver cancer cases are due to preventable risk factors Researchers from Clínic-IDIBAPS have participated in a Lancet Commission with international experts highlighting that more than 60% of liver cancer cases could be prevented. 👉f.mtr.cool/kdwrkperon